Almost 90% hospitalizations related to Covid-19 and deaths reduced in people at risk when taken in the first days after the onset of symptoms.

Pfizer confirmed this Tuesday the very positive results of its anti-Covid-19 pill.

No deaths were recorded among the more than 2,200 study participants who received the treatment.

Participants were unvaccinated and at high risk of developing a severe case of Covid-19.

"This highlights the potential of this (drug) candidate to save the lives of patients around the world," said Albert Bourla, CEO of Pfizer, quoted in a statement.

Variants of concern like Omicron have exacerbated the need for accessible treatment options for those who contract the virus.

"

Very easy to administer

Antivirals work by decreasing the ability of a virus to replicate, thereby slowing down the disease.

These treatments represent a key complement to vaccines to protect against Covid-19, in particular because they are very easy to administer, being able to be taken simply at home with a large glass of water.

Pfizer, which is the source of one of the most widely used Covid-19 vaccines in the world, has also announced that its antiviral treatment, which will be marketed as Paxlovid, is expected to remain effective against the Omicron variant. .

Health

Coronavirus: Monoclonal antibodies, antiviral tablets ... Five promising treatments against Covid-19 scrutinized

World

Coronavirus: United States orders ten million Pfizer anti-Covid pill

  • Covid 19

  • Pfizer-BioNTech

  • Coronavirus

  • Health

  • 0 comment

  • 0 share

    • Share on Messenger

    • Share on Facebook

    • Share on twitter

    • Share on Flipboard

    • Share on Pinterest

    • Share on Linkedin

    • Send by Mail

  • To safeguard

  • A fault ?

  • To print